Evidence map›Paper›PMID 33513766›Full record

ArticleCells2021

Spermatogonia Loss Correlates with LAMA 1 Expression in Human Prepubertal Testes Stored for Fertility Preservation.

Magdalena Kurek, Elisabet Åkesson, Masahito Yoshihara, Elizabeth Oliver, Yanhua Cui, Martin Becker, João Pedro Alves-Lopes, Ragnar Bjarnason, Patrik Romerius, Mikael Sundin and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 5 countries.

Magdalena KurekNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.
Elisabet ÅkessonDivision of Neurogeriatrics, Department of Neurobiology Care Sciences & Society, Karolinska Institutet, 141 83 Huddinge, Sweden.
Masahito YoshiharaDepartment of Biosciences and Nutrition, Karolinska Institutet, 141 83 Huddinge, Sweden.ORCID 0000-0002-8915-9282
Elizabeth OliverNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.ORCID 0000-0002-3500-8323
Yanhua CuiNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.
Martin BeckerCenter of Neurodevelopmental Disorders (KIND), Department of Women's and Children's Health, Karolinska Institutet, Centre for Psychiatry Research, Region Stockholm and Astrid Lindgren Children's Hospital, Karolinska University Hospital, 171 64 Solna, Sweden.ORCID 0000-0001-8442-4246
João Pedro Alves-LopesNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.
Ragnar BjarnasonChildren's Medical Center, Landspítali University Hospital, 101 Reykjavik, Iceland.
Patrik RomeriusDepartment of Paediatric Oncology and Haematology, Clinical Sciences, Lund University, Barn-och Ungdomssjukhuset Lund, Skånes Universitetssjukhus, 221 85 Lund, Sweden.
Mikael SundinDivision of Paediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 141 52 Huddinge, Sweden.ORCID 0000-0002-9871-0961
Ulrika Norén NyströmDivision of Paediatrics, Department of Clinical Science, Umeå University, 901 87 Umeå, Sweden.
Cecilia LangenskiöldDepartment of Paediatric Oncology, The Queen Silvia Children's Hospital, 416 50 Gothenburg, Sweden.
Hartmut VogtCrown Princess Victoria's Child and Youth Hospital, and Department of Biomedical and Clinical Sciences, Linköping University, 581 83 Linköping, Sweden.
Lars HenningsohnDivision of Urology, Institution for Clinical Science Intervention and Technology, Karolinska Institutet, 141 52 Huddinge, Sweden.
Cecilia PetersenNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.
Olle SöderNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.
Jingtao GuoDivision of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.ORCID 0000-0002-0159-5021
Rod T MitchellMRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, UK.ORCID 0000-0003-4650-3765
Kirsi JahnukainenNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.
Jan-Bernd StukenborgNORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Karolinska University Hospital, 171 64 Solna, Sweden.ORCID 0000-0002-2839-1870
Karolinska University Hospital · SEKarolinska Institutet · SEDrottning Silvias barn- och ungdomssjukhus · SELinköping University Hospital · SELund University · SERoyal Hospital for Children · GBUmeå University · SEUniversity of Iceland · ISUniversity of Utah · US

Funding

Medical Research Council MR/N022556/1Medical Research Council MR/R006237/1Medical Research Council MR/S017151/1Wellcome Trust
6 · The paper itself

Abstract

Fertility preservation for male childhood cancer survivors not yet capable of producing mature spermatozoa, relies on experimental approaches such as testicular explant culture. Although the first steps in somatic maturation can be observed in human testicular explant cultures, germ cell depletion is a common obstacle. Hence, understanding the spermatogonial stem cell (SSC) niche environment and in particular, specific components such as the seminiferous basement membrane (BM) will allow progression of testicular explant cultures. Here, we revealed that the seminiferous BM is established from 6 weeks post conception with the expression of laminin alpha 1 (LAMA 1) and type IV collagen, which persist as key components throughout development. With prepubertal testicular explant culture we found that seminiferous LAMA 1 expression is disrupted and depleted with culture time correlating with germ cell loss. These findings highlight the importance of LAMA 1 for the human SSC niche and its sensitivity to culture conditions.

Indexed as

Fertility PreservationBasement MembraneCollagen Type IVFibronectinsHumansLamininMaleModels, BiologicalPubertySeminiferous TubulesSpermatogoniaSpermatozoaTestisTranscription, GeneticCollagen Type IVFibronectinsLamininlaminin Abasal membranegerm cellsinfertilitylate effectsseminiferous tubulesSertoli cellsspermatogoniastem cell niche

Identifiers

PMID33513766
PMCPMC7911157
OpenAlexW3125826001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.